BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191119
DTEND;VALUE=DATE:20191122
DTSTAMP:20260515T032538
CREATED:20190910T085210Z
LAST-MODIFIED:20190910T085210Z
UID:22357-1574121600-1574380799@www.pharmajournalist.com
SUMMARY:3rd Annual Dermatology Drug Development Summit
DESCRIPTION:The Dermatology Drug Development Summit series is a unique industry-focused forum dedicated to innovating\, accelerating and sharing pharmaceutical best practice on the development and bringing to market of new dermatological drugs\, in the treatment of high unmet need. \nThe 3rd Annual Dermatology Drug Development Summit provides leading industry experts with a unique forum to debate the end-to-end challenges in dermatology drug development: from discovering new research on key disease pathways\, to unveiling critical preclinical insights\, discussing formulation strategies\, defining the optimal clinical development plans or evaluating commercialization approaches. \nJoin peers and leaders in this space for an exclusive three-day meeting of comprehensive discussion\, sharing of latest advances and pioneering insights\, and networking opportunities. \nHear from 30+ experts including: \n\nSonya Abraham\, Head of New Treatment Strategies\, Immunology\, UCB\nDavid Rubenstein\, CSO\, Dermavant Sciences\nKendall Marcus\, Director – Division of Dermatology & Dental Products\, FDA\nMichael Kuligowski\, Executive Medical Director – Inflammation & Autoimmunity\, Incyte Corporation\nJohn Harris\, Vice Chair of Dermatology & Director\, Vitiligo Clinic & research Center\, University of Massachusetts Medical School\nSuma Krishnan\, Founder & COO\, Krystal Biotech\n\nAcross an end-to-end\, comprehensive agenda\, learn from case studies on: \n\nHow to enhance preclinical activities\nThe latest advances in translational research\nHow to advance topical drug development and formulation approaches\nHow to accelerate clinical development and what are the latest clinical results\nHow to tackle the evolving regulatory and commercial landscape in dermatology\n\nFind out more here: https://ter.li/jj7wxg
URL:https://www.pharmajournalist.com/event/3rd-annual-dermatology-drug-development-summit/
LOCATION:Aloft Boston Seaport District\, Boston\, MA
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191119
DTEND;VALUE=DATE:20191122
DTSTAMP:20260515T032538
CREATED:20190924T113636Z
LAST-MODIFIED:20190924T113636Z
UID:22548-1574121600-1574380799@www.pharmajournalist.com
SUMMARY:Gene Therapy Analytical Development
DESCRIPTION:The inaugural Gene Therapy Analytical Development Summit will unite large pharma and innovative biotechs to develop robust analytical tools to guarantee the consistency\, quality and safety of gene therapy products. \n \nFocused specifically on addressing the unique analytical challenges posed by gene therapy vectors\, this technical scientific meeting will unite the ‘boots on the ground’ scientists grappling with these challenges first-hand. \nDelving into technical analytics to assess potency\, capsid integrity\, empty vs full capsids and viral titers of AAV and lentiviral vectors\, this is your opportunity to enhance your existing analytical methods and explore innovative novel tools to support safe and effective gene therapy development. \nTo learn more and to register online\, visit https://ter.li/z1fc6v
URL:https://www.pharmajournalist.com/event/gene-therapy-analytical-development/
LOCATION:Renaissance Boston Waterfront Hotel 606 Congress Street Boston\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR